4-102500997-CATTG-C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The ENST00000966659.1(NFKB1):​c.-794_-791delATTG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.427 in 153,546 control chromosomes in the GnomAD database, including 14,272 homozygotes. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 14166 hom., cov: 0)
Exomes 𝑓: 0.32 ( 106 hom. )

Consequence

NFKB1
ENST00000966659.1 5_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0720

Publications

327 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.489 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000966659.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1-AS1
NR_136202.1
n.48+1438_48+1441delCAAT
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
ENST00000966659.1
c.-794_-791delATTG
5_prime_UTR
Exon 1 of 24ENSP00000636718.1
ENSG00000260651
ENST00000563833.1
TSL:6
n.319_322delCAAT
non_coding_transcript_exon
Exon 1 of 1
NFKB1-AS1
ENST00000843825.1
n.49+1438_49+1441delCAAT
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.428
AC:
64938
AN:
151662
Hom.:
14138
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.494
Gnomad AMI
AF:
0.359
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.333
Gnomad EAS
AF:
0.402
Gnomad SAS
AF:
0.298
Gnomad FIN
AF:
0.447
Gnomad MID
AF:
0.297
Gnomad NFE
AF:
0.391
Gnomad OTH
AF:
0.402
GnomAD4 exome
AF:
0.323
AC:
570
AN:
1764
Hom.:
106
AF XY:
0.327
AC XY:
353
AN XY:
1080
show subpopulations
African (AFR)
AF:
0.350
AC:
7
AN:
20
American (AMR)
AF:
0.429
AC:
6
AN:
14
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
5
AN:
36
East Asian (EAS)
AF:
0.313
AC:
50
AN:
160
South Asian (SAS)
AF:
0.167
AC:
12
AN:
72
European-Finnish (FIN)
AF:
0.489
AC:
44
AN:
90
Middle Eastern (MID)
AF:
0.167
AC:
2
AN:
12
European-Non Finnish (NFE)
AF:
0.331
AC:
421
AN:
1270
Other (OTH)
AF:
0.256
AC:
23
AN:
90
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.428
AC:
65010
AN:
151782
Hom.:
14166
Cov.:
0
AF XY:
0.429
AC XY:
31815
AN XY:
74188
show subpopulations
African (AFR)
AF:
0.494
AC:
20462
AN:
41388
American (AMR)
AF:
0.485
AC:
7412
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.333
AC:
1155
AN:
3468
East Asian (EAS)
AF:
0.403
AC:
2073
AN:
5150
South Asian (SAS)
AF:
0.297
AC:
1435
AN:
4826
European-Finnish (FIN)
AF:
0.447
AC:
4714
AN:
10542
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.391
AC:
26510
AN:
67844
Other (OTH)
AF:
0.398
AC:
836
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1910
3820
5731
7641
9551
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.416
Hom.:
1645
Bravo
AF:
0.439
Asia WGS
AF:
0.354
AC:
1226
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.072

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28362491; hg19: chr4-103422154; API